UPA Tidlira 30mg Pen - Tirzepatide
Advanced Dual-Action GLP-1 + GIP Therapy for Weight Management and Type 2 Diabetes
TIDLIRA™ is a next-generation injectable treatment powered by Tirzepatide, a breakthrough dual receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action helps regulate blood sugar, control appetite, and promote significant, sustainable weight loss.
Originally developed by Eli Lilly & Co. under the brand name Mounjaro®, Tirzepatide is now globally recognized for its ability to transform metabolic health by addressing both type 2 diabetes and obesity through a single, comprehensive mechanism.
How It Works
Tirzepatide mimics the body’s natural GIP and GLP-1 hormones, which are responsible for regulating glucose and appetite.
When activated together, these pathways:
Stimulate insulin secretion when blood sugar is high
Reduce glucagon release (which prevents sugar spikes)
Slow gastric emptying for longer fullness
Decrease appetite and calorie intake
This dual mechanism supports effective glycemic control and accelerated fat reduction — without the crash diets or extreme routines.
Key Benefits
Supports healthy blood sugar control
Reduces hunger and promotes satiety
Encourages steady, long-term weight loss
Once-weekly self-injection
Clinically proven and pharmaceutical grade
Concentration: 10mg/ml
Injection Type: Subcutaneous (once weekly)
Syringe Type: Built-in dial with preset delivery
Storage: Refrigerate at 2–8°C. Store up to 30 days at below 25°C.
Frequency: Inject once weekly — same day and time each week
Do not shake or freeze. Use only if solution is clear.
One pen lasts 2–12 weeks, depending on your individual dose.
Recommended Dosing Schedule
| Weeks | Dose (mg) | Volume (ml) | Notes |
|---|---|---|---|
| 1-2 | 2.5mg | 0.25ml | Initiation phase |
| 3-4 | 5.0mg | 0.5ml | Begin fat loss effect |
| 5-6 | 7.5mg | 0.75ml | Enhanced insulin control |
| 7–8 | 10.0mg | 1.0ml | Ideal maintenance dose |
Tirzepatide should be increased gradually to minimize nausea and digestive discomfort.
TIDLIRA™ Tirzepatide 10mg/ml delivers cutting-edge dual-action GLP-1 and GIP support for individuals committed to real, lasting results. With its weekly dosing convenience, precision formulation, and proven clinical performance, it’s the modern solution for weight management and type 2 diabetes control.
Details
This product is crafted with quality materials to ensure durability and performance. Designed with your convenience in mind, it seamlessly fits into your everyday life.
Shipping & Returns
We strive to process and ship all orders in a timely manner, working diligently to ensure that your items are on their way to you as soon as possible.
We are committed to ensuring a positive shopping experience for all our customers. If for any reason you wish to return an item, we invite you to reach out to our team for assistance, and we will evaluate every return request with care and consideration.